Timothy Kinsella

Timothy Kinsella is a distinguished Research Scholar Professor at Brown University, where involvement spans clinical and translational research, clinical care, and teaching. Kinsella has played a pivotal role in advancing cancer treatment, particularly through the Phase 1 clinical trial of IPdR as a radiosensitizing drug for GI cancers, and has received FDA Orphan Drug Designation for gliomas. Prior experiences include leadership roles at Stony Brook University as the Kenney Professor and Cancer Center Director, and at Case Western Reserve University, serving as the founding Chairman of the Department of Radiation Oncology. Kinsella's academic credentials include an M.D. and M.S. from the University of Rochester School of Medicine and Dentistry, and a Bachelor of Science from St. John Fisher University.